ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Short Interest Update

ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIBGet Free Report) was the recipient of a large decrease in short interest in October. As of October 31st, there was short interest totalling 7,600 shares, a decrease of 54.8% from the October 15th total of 16,800 shares. Based on an average daily trading volume, of 11,400 shares, the days-to-cover ratio is currently 0.7 days.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in ProShares Ultra Nasdaq Biotechnology stock. Texas Capital Bank Wealth Management Services Inc bought a new position in shares of ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIBFree Report) during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 5,000 shares of the exchange traded fund’s stock, valued at approximately $288,000. Texas Capital Bank Wealth Management Services Inc owned approximately 0.31% of ProShares Ultra Nasdaq Biotechnology as of its most recent filing with the SEC.

ProShares Ultra Nasdaq Biotechnology Stock Performance

NASDAQ BIB traded down $5.31 on Friday, reaching $53.66. The stock had a trading volume of 28,845 shares, compared to its average volume of 23,659. The firm has a fifty day moving average of $63.48 and a two-hundred day moving average of $61.83. ProShares Ultra Nasdaq Biotechnology has a 1-year low of $42.42 and a 1-year high of $69.56.

ProShares Ultra Nasdaq Biotechnology Increases Dividend

The company also recently disclosed a dividend, which was paid on Wednesday, October 2nd. Shareholders of record on Wednesday, September 25th were issued a $0.1528 dividend. This is a positive change from ProShares Ultra Nasdaq Biotechnology’s previous dividend of $0.04. The ex-dividend date was Wednesday, September 25th.

About ProShares Ultra Nasdaq Biotechnology

(Get Free Report)

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period.

Further Reading

Receive News & Ratings for ProShares Ultra Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares Ultra Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.